Evolent Health, Inc.
EVH
$4.72
-$0.02-0.42%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.50% | -21.26% | -26.56% | -16.65% | -6.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.50% | -21.26% | -26.56% | -16.65% | -6.71% |
| Cost of Revenue | -5.51% | -25.84% | -32.51% | -19.09% | -4.18% |
| Gross Profit | 0.66% | 4.23% | 8.86% | -3.80% | -17.79% |
| SG&A Expenses | 6.23% | 11.63% | 16.97% | 11.93% | -2.42% |
| Depreciation & Amortization | 32.13% | 24.11% | 19.72% | -33.85% | -30.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.65% | -19.92% | -25.69% | -16.69% | -5.35% |
| Operating Income | -309.89% | -182.05% | -118.51% | -13.03% | -72.22% |
| Income Before Tax | -281.71% | -354.20% | -748.14% | -46.54% | -39.50% |
| Income Tax Expenses | 360.64% | -35.04% | 91.08% | 102.88% | 94.49% |
| Earnings from Continuing Operations | -287.10% | -355.69% | -767.39% | -77.46% | -75.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -287.10% | -355.69% | -767.39% | -77.46% | -75.30% |
| EBIT | -309.89% | -182.05% | -118.51% | -13.03% | -72.22% |
| EBITDA | -16.80% | -13.12% | -7.27% | -34.16% | -48.67% |
| EPS Basic | -184.72% | -290.08% | -531.93% | -71.92% | -71.39% |
| Normalized Basic EPS | -33.27% | -27.58% | -8,052.63% | -986.00% | -467.01% |
| EPS Diluted | -184.72% | -290.08% | -531.93% | -71.92% | -71.39% |
| Normalized Diluted EPS | -33.27% | -27.58% | -8,052.63% | -986.00% | -467.01% |
| Average Basic Shares Outstanding | -2.38% | -1.40% | -0.40% | 0.66% | 1.41% |
| Average Diluted Shares Outstanding | -2.38% | -1.40% | -0.40% | 0.66% | 1.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.97% | 0.93% | 0.94% | 0.56% | 0.46% |